Copyright
©The Author(s) 2019.
World J Gastroenterol. Jul 7, 2019; 25(25): 3196-3206
Published online Jul 7, 2019. doi: 10.3748/wjg.v25.i25.3196
Published online Jul 7, 2019. doi: 10.3748/wjg.v25.i25.3196
Figure 2 Establishment of a colorectal cancer in vivo model.
Photos taken of intestines from the vehicle group (A) and sporamin-treated group (B). C: Tumor shapes are shown.
- Citation: Yang C, Zhang JJ, Zhang XP, Xiao R, Li PG. Sporamin suppresses growth of xenografted colorectal carcinoma in athymic BALB/c mice by inhibiting liver β-catenin and vascular endothelial growth factor expression. World J Gastroenterol 2019; 25(25): 3196-3206
- URL: https://www.wjgnet.com/1007-9327/full/v25/i25/3196.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i25.3196